We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oscient Pharmaceuticals and Ethypharm have received notice that Lupin has filed an ANDA to market a generic version of the cardiovascular drug Antara before the expiration of patent protection.